2401 ELLIOTT AVENUE, SEATTLE, WA
To Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma
Provides Recent Business Highlights and Reports 1Q 2026 Results
Financial Results, Other Events
Investor Presentation
Q1
FY 2025
Q3
Q2
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Specialized Disclosure Report
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement